Motif Bio Plc MTFB

Other — Other

Market cap: —
P/E: 0.0×

Follow MTFB

Overview Business Profile Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions

in millions of $

	Nov 25			Feb 26			May 26			Aug 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership —

Capital & Financial Ratios

Market Cap —

Revenue —

Net Income (40.06)

Free Cash Flow (34.56)

Net Debt (0.80)

Current Ratio 1.31

Debt/Equity 0.00

P/E ratio 0.00

P/S ratio —

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth —

Next Y EPS Growth —

Next 5Y EPS Growth —

in millions of $

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2020	Powerpack
2019	Powerpack
2018	Powerpack

predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

	2017	2018	2019	Q'20
Cash	23	12	1	1
Receivables	—	—	—	—
Inventory	—	—	—	—
Other	—	—	—	—
	23	13	1	1

	2017	2018	2019	Q'20
Payables	11	7	0	0
ST’ Debt	—	4	—	—
Other	13	6	0	1
	24	17	0	1

in millions of $

Compound Annual Growth

	10y	5y	3y
Sales	—	—	—
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	0.00%

Revenue

	Year

in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

	Mar	Jun	Sep	Dec	Year
’26	—	(1)	—	—	—
’19	—	(5)	—	(7)	(7)
’18	—	(15)	—	(21)	(21)
’17	—	(16)	—	(37)	(37)

in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

	Mar	Jun	Sep	Dec	Year
’26	—	(1)	—	—	—
’19	—	(5)	—	(7)	(7)
’18	—	(15)	—	(21)	(21)
’17	—	(16)	—	(37)	(37)

in millions of $ · fiscal quarters ending in the months shown

EPS

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’19	—	—	—	—	0.24
’18	—	—	—	—	0.34
’17	—	—	—	—	(3.87)

fiscal quarters ending in the months shown

2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020
—	—	—	—	—	—	—	—	—	—	Analyst estimates 2020–2022 Powerpack	Low Price
—	—	—	—	—	—	—	—	—	—		High Price
—	—	—	—	—	—	6	8	7	6		Employees
—	—	—	—	—	—	0	0	0	0		Revenue/Emp
—	—	—	—	—	—	—	—	—	—		Revenue
—	—	—	—	—	—	—	—	—	—		Gross Margin
—	—	—	—	—	—	(40)	(45)	5	4		EBT
—	—	—	—	—	—	0.00%	0.00%	0.00%	0.00%		EBT Margin
—	—	—	—	—	—	(40)	(38)	(19)	(10)		Net Income
—	—	—	—	—	—	—	—	—	—		Depreciation
—	—	—	—	—	—	0.00	0.00	0.00	0.00		Revenue/Sh
—	—	—	—	—	—	(6.92)	(3.87)	0.34	0.24		Earnings/Sh
—	—	—	—	—	—	(4.79)	(3.23)	(1.51)	(0.40)		Cash Flow/Sh
—	—	—	—	—	—	0.00	0.00	0.00	0.00		Capex/Sh
—	—	—	—	—	—	(4.79)	(3.23)	(1.51)	(0.40)		Free CF/Sh
—	—	—	—	—	—	1.68	(0.77)	(0.63)	(0.64)		Book Value/Sh
—	—	—	—	—	—	6	12	14	18		Shares
—	—	—	—	—	—	—	—	—	—		PE Ratio
—	—	—	—	—	—	—	—	—	—		PS Ratio
—	—	—	—	—	—	—	—	—	—		PB Ratio
—	—	—	—	—	—	—	—	—	—		EV/Sales
—	—	—	—	—	—	—	—	—	—		EV/FCF
—	—	—	—	—	—	(28)	(37)	(21)	(7)		Op' Cash Flow
—	—	—	—	—	—	—	—	—	—		Capex
—	—	—	—	—	—	(28)	(37)	(21)	(7)		FCF
—	—	—	—	—	—	4	(1)	(5)	0		Working Cap'
—	—	—	—	—	—	—	14	14	—		Total Debt
—	—	—	—	—	—	(22)	(9)	2	(1)		Net Debt
—	—	—	—	—	—	10	(9)	(9)	(11)		Sh' Equity
—	—	—	—	—	—	(127.24%)	(155.55%)	20.23%	43.28%		ROA
—	—	—	—	—	—	0.00%	0.00%	0.00%	0.00%		ROIC
—	—	—	—	—	—	(204.01%)	(9,943.42%)	(54.35%)	(42.08%)		ROE

predictions in italic, sparklines do not include predictions

All 10 years →